NCT04935710View on ClinicalTrials.gov

Prevention and Early Identification for High Risk Youth in School-based Clinics

PHASE1CompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

February 28, 2024

Study Completion Date

March 31, 2024

Conditions
Community Mental Health ServicesAdolescent Well BeingResilience, PsychologicalHealth EquityScreening
Interventions
BEHAVIORAL

COPE2Thrive

Cognitive Behavioral Therapy-based program to help teens deal with anxiety, stress and depression by showing them how to develop skills needed to stop negative thoughts and start thinking and behaving in more positive ways.

GENETIC

Usual care

Children at risk who are not randomized to COPE2Thrive at any point of time serve as the control group.

Trial Locations (5)

02138-4125

CHA-Teen Health Center at Cambridge Rindge and Latin School, Cambridge

02138

Community, Cambridge

02141-1047

CHA Health Equity Research Lab, Cambridge

02149-5128

CHA Teen Health Center at Everett High School, Everett

02143-1740

CHA Teen Connections at Somerville High School, Somerville

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Cambridge Health Alliance

OTHER

NCT04935710 - Prevention and Early Identification for High Risk Youth in School-based Clinics | Biotech Hunter | Biotech Hunter